Viral hepatitis amidst COVID-19 in Africa: Implications and recommendations.

Autor: Kazmi SK; Department of General Medicine, Dow University of Health Sciences, Karachi, Pakistan., Khan FMA; Department of General Medicine, Dow University of Health Sciences, Karachi, Pakistan., Natoli V; Department of Dentistry, School of Biomedical and Health Sciences, European University of Madrid, Madrid, Spain., Hunain R; Department of General Medicine, Kasturba Medical College, Manipal, India., Islam Z; Department of General Medicine, Dow University of Health Sciences, Karachi, Pakistan., Costa ACDS; Department of General Medicine, Federal University of Bahia, Salvador, Bahia, Brazil., Ahmad S; Department of General Medicine and Surgery, District Head Quarters Teaching Hospital, Faisalabad, Pakistan., Essar MY; Faculty of Dentistry, Kabul University of Medical Sciences, Kabul, Afghanistan.
Jazyk: angličtina
Zdroj: Journal of medical virology [J Med Virol] 2022 Jan; Vol. 94 (1), pp. 7-10. Date of Electronic Publication: 2021 Sep 18.
DOI: 10.1002/jmv.27330
Abstrakt: Hepatitis, a significant cause of mortality worldwide, results in around 1.34 million deaths each year globally. Africa is not exempt from the plague of Hepatitis. Around 100 million estimated individuals are infected with Hepatitis B or C. Egypt has the highest prevalence of cases of Hepatitis followed by Cameroon and Burundi. The continent is severely affected by the onset of the COVID-19 pandemic, as the virus has added an additional burden on the already fragile continent. With the pandemic, it is presumable that Hepatitis like other viral diseases will pose a threat to collapsing healthcare system. Therefore, for Africa to become more resilient in the face of such menaces, including Hepatitis, further prevention policies are required to be implemented.
(© 2021 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: